Skip to main content

RenX Enterprises Corp.

For the period ended Dec 31, 2025. Filed Apr 1, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Apr 1, 2026

RENX$1.03-2.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

December 31,December 31,
20252024
Assets
Current Assets
Cash$54,066$227,766
Prepaid assets and other current assets638,166502,883
Inventory1,078,610-
Accounts receivable, net799,068-
Notes receivable, net-960,672
Current assets of discontinued operations-112,849
Current Assets2,569,9101,804,170
Assets held for sale-4,400,361
Land2,393,785807,847
Property and equipment, net11,802,2486,045
Project development costs and other non-current assets91,28996,239
Equity-based investments828,4403,642,607
Intangible assets, net11,260,3651,038,312
Right of use assets290,092-
Goodwill6,240,432-
Long-term assets of discontinued operations-958,211
Total Assets$35,476,561$12,753,792
Liabilities and Stockholder’s Equity
Current Liabilities
Accounts payable and accrued expenses$5,530,211$1,293,921
Due to affiliates2,094,833399,660
Short-term notes payable, net6,956,2598,361,655
Notes payable - related party, current5,562,266-
Operating lease liabilities, current60,446-
Finance lease liabilities, current183,359-
Derivative liability1,218,258-
Current liabilities of discontinued operations-345,421
Total Current Liabilities21,605,63210,400,657
Long-term notes payable, net8,243,6781,499,957
Operating lease liabilities250,119-
Finance lease liabilities982,887-
Total Liabilities31,082,31611,900,614
Stockholder’s Equity:
Preferred Series A stock, $0.001 par value, 5,000,000 shares authorized,938,847 issued and outstanding as of December 31, 2025, 0 issued and outstanding as of December 31, 2024939-
Preferred Series B stock, $0.001 par value, 360,000 shares authorized,327,811 issued and outstanding as of December 31, 2025, 0 issued and outstanding as of December 31, 2024326-
Common stock, $0.001 par value, 100,000,000 shares authorized, 946,742 issued and 938,559 outstanding as of December 31, 2025 and 74,344 shares authorized and 60,522 shares, issued and outstanding as of December 31, 202494774
Additional paid-in capital36,565,51316,660,564
Treasury stock, at cost – 8,183 and 13,821 shares at December 31, 2025 and December 31, 2024, respectively--
Accumulated deficit(32,173,480)(16,039,022)
Non-controlling interest-231,562
Total Stockholder’s Equity4,394,245853,178
Total Liabilities and Stockholder’s Equity$35,476,561$12,753,792
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.